DP
MGNX icon

Diadema Partners’s MacroGenics MGNX Stock Holding History

Diadema Partners’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Sell
374,403
-225,597
-38% -$853K 0.22% 83
2026
Q1 		$1.73M Buy
+600,000
New +$1.28M 0.3% 68

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Diadema Partners's MGNX Position: Q2 2026 in Review

Diadema Partners reduced its MacroGenics (MGNX) stake by 38% in Q2 2026, selling an estimated $853K and leaving 374,403 shares worth $1.73M. The position accounts for 0.22% of the portfolio, ranked #83.

Diadema Partners first reported a position in MGNX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.73M in Q1 2026. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Diadema Partners held 374,403 shares of MacroGenics worth $1.73M as of Q2 2026.
  • Diadema Partners sold 225,597 MacroGenics shares in Q2 2026, an estimated $853K.
  • MacroGenics made up 0.22% of Diadema Partners's portfolio in Q2 2026, its #83 holding.
  • Diadema Partners first reported a position in MacroGenics in Q1 2026 and has held it in 2 quarters since.
  • Diadema Partners's MacroGenics position peaked at $1.73M in Q1 2026.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.